Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
This Month's Highlights
You have accessRestricted Access

This Month’s Highlights

JASN January 2009, 20 (1) A11; DOI: https://doi.org/10.1681/ASN.2008111198
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

BASIC RESEARCH

HNF-1β Meets Its Target

Mutations in the transcription factor hepatocyte nuclear factor 1β (HNF-1β) lead to cystic renal disease, but the relevant gene targets of HNF-1β are unknown. Using a functional genomics approach, Gong et al. found that HNF-1β regulates kinesin family member 12 (Kif12), a proposed candidate modifier gene in a mouse model of polycystic kidney disease. They show that lack of HNF-1β inhibits transcription of Kif12 by altering the recruitment of coactivators, which modifies histone acetylation and chromatin remodeling. In vivo, Kif12 is reduced in cystic kidneys from HNF-1β mutant mice. These results support a role for Kif12 in polycystic kidney disease. See Gong et al., pages 41–47.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Imatinib Treats Cryoglobulinemia and MPGN

Reliable therapies are not available for cryoglobulinemia and its associated membranoproliferative GN (MPGN). In an animal model that closely mimics this human disease, enhanced expression of PDGF-B and its receptor, PDGFRβ, correlates with glomerular cell proliferation and matrix expansion. Here, Iyoda et al. report that imatinib, which inhibits PDGFR, attenuates not only the development of renal manifestations but also the systemic features of cryoglobulinemia in this animal model. Furthermore, imatinib reverses established lesions. These data suggest that imatinib may have therapeutic potential for cryoglobulinemia and MPGN in humans. See Iyoda et al. on pages 68–77.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Al dosterone Activates NF-κB in Collecting Duct

Mounting evidence supports roles for aldosterone in inflammation, fibrosis, cell proliferation, and apoptosis in addition to sodium reabsorption in the collecting duct. The transcription factor NF-κB has been implicated in each of these processes, but its relationship with aldosterone is incompletely understood. Here, Leroy et al. report that aldosterone acts through the mineralocorticoid receptor to upregulate the serum and glucocorticoid-inducible kinase (SGK1), thereby activating NF-κB signaling in the collecting duct. These data suggest that activation of NF-κB by aldosterone in the collecting duct may promote renal inflammation and fibrosis, as well as modulate salt and water homeostasis. See Leroy et al. on pages 131–144.

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL EPIDEMIOLOGY

A Fresh Look at the Dialysis Modality Debate

Despite years of debate, the mortality benefits of peritoneal dialysis (PD) or hemodialysis (HD) remain controversial. McDonald et al. analyzed data from more than 27,000 patients treated with PD or HD. Categorizing patients by modality used at day 90, they found that PD conferred a survival advantage for the first year, but this effect was driven by younger patients without comorbidities. However, after 1 yr of dialytic therapy, PD was associated with a 30% increased risk for mortality overall. These results suggest that the mortality risks associated with dialysis modality may be dependent on time and patient characteristics such as age and comorbidities. See McDonald et al. on pages 155–163.

Figure4
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL RESEARCH

Improved Ultrasonographic Criteria for PKD

Current ultrasonographic criteria for the diagnosis of polycystic kidney disease (PKD) were established from individuals with mutations in PKD1. These criteria may lead to false-negative results for patients with mutations in PKD2, who typically have less severe disease. Pei et al. assessed 577 and 371 at-risk subjects from PKD1 and PKD2 families, respectively, with ultrasound and molecular genotyping. They report that current diagnostic criteria are insensitive for the detection of PKD among individuals with PKD2 mutations and propose new criteria to be used when diagnosing at-risk individuals of unknown genotype by ultrasonography. See Pei et al. on pages 205–212.

Figure5
  • Download figure
  • Open in new tab
  • Download powerpoint

Elderly with AKI at Risk for ESRD

The risk for ESRD among elderly patients who suffer acute kidney injury (AKI) is unknown. Combining data from Medicare claims and ESRD registration, Ishani et al. demonstrate that, after adjustment for multiple confounders, elderly patients with AKI have a seven-fold higher risk of developing ESRD compared with those who do not develop AKI. Pre-existing chronic kidney disease (CKD) significantly increases this risk; elderly patients with CKD who develop AKI have a 40-fold risk for progression to ESRD compared with those who have neither diagnosis. These results support close monitoring of kidney function after AKI in elderly patients and provide further impetus to develop strategies to reduce AKI. See Ishani et al. on pages 223–228.

Figure6
  • Download figure
  • Open in new tab
  • Download powerpoint
  • Copyright © 2009 by the American Society of Nephrology
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 20 (1)
Journal of the American Society of Nephrology
Vol. 20, Issue 1
January 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
This Month’s Highlights
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
This Month’s Highlights
JASN Jan 2009, 20 (1) A11; DOI: 10.1681/ASN.2008111198

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
This Month’s Highlights
JASN Jan 2009, 20 (1) A11; DOI: 10.1681/ASN.2008111198
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • BASIC RESEARCH
    • CLINICAL EPIDEMIOLOGY
    • CLINICAL RESEARCH
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • This Month's Highlights
  • This Month's Highlights
  • This Month's Highlights
Show more This Month's Highlights

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • HNF-1β Regulates Transcription of the PKD Modifier Gene Kif12
  • Imatinib Suppresses Cryoglobulinemia and Secondary Membranoproliferative Glomerulonephritis
  • Aldosterone Activates NF-κB in the Collecting Duct
  • Relationship between Dialysis Modality and Mortality
  • Unified Criteria for Ultrasonographic Diagnosis of ADPKD
  • Acute Kidney Injury Increases Risk of ESRD among Elderly
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire